Importantly, these results provide experimental support for the TPP1–α-synuclein relationship predicted by our knowledge graph–based AI model, highlighting the biological relevance of TPP1 as a potential therapeutic target in PD. The gene discussed is SNCA; the disease is Parkinson disease.